These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 22237257
41. A knowledge based approach for automated signal generation in pharmacovigilance. Henegar C, Bousquet C, Lillo-Le Louët A, Degoulet P, Jaulent MC. Stud Health Technol Inform; 2004; 107(Pt 1):626-30. PubMed ID: 15360888 [Abstract] [Full Text] [Related]
42. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities. Frid AA, Matthews EJ. Regul Toxicol Pharmacol; 2010 Apr; 56(3):276-89. PubMed ID: 19941924 [Abstract] [Full Text] [Related]
46. Reporting adverse effects: a practice to be encouraged. Prescrire Int; 2013 Mar; 22(136):83. PubMed ID: 23593701 [No Abstract] [Full Text] [Related]
47. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW. Arch Intern Med; 2007 May 28; 167(10):1041-9. PubMed ID: 17533207 [Abstract] [Full Text] [Related]
48. Systematic investigation of time windows for adverse event data mining for recently approved drugs. Hochberg AM, Hauben M, Pearson RK, O'Hara DJ, Reisinger SJ. J Clin Pharmacol; 2009 Jun 28; 49(6):626-33. PubMed ID: 19451402 [Abstract] [Full Text] [Related]
50. Pharmacovigilance in India: how safe are the new drugs? How sure are we? Joshi SR, Sapatnekar SM. J Assoc Physicians India; 2008 Dec 28; 56():933-4. PubMed ID: 19322970 [No Abstract] [Full Text] [Related]
56. Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence. Matthews EJ, Frid AA. Regul Toxicol Pharmacol; 2010 Apr 28; 56(3):247-75. PubMed ID: 19932726 [Abstract] [Full Text] [Related]
57. Grouping pharmacovigilance terms with semantic distance. Dupuch M, Lerch M, Jamet A, Jaulent MC, Fescharek R, Grabar N. Stud Health Technol Inform; 2011 Apr 28; 169():794-8. PubMed ID: 21893856 [Abstract] [Full Text] [Related]
58. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pariente A, Didailler M, Avillach P, Miremont-Salamé G, Fourrier-Reglat A, Haramburu F, Moore N. Pharmacoepidemiol Drug Saf; 2010 Nov 28; 19(11):1166-71. PubMed ID: 20848561 [Abstract] [Full Text] [Related]
59. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation. Hauben M, Reich L. J Clin Pharmacol; 2005 Apr 28; 45(4):378-84. PubMed ID: 15778418 [Abstract] [Full Text] [Related]